Precision medicine: Clarity for the complexity of dementia

Brenna Cholerton, Eric B. Larson, Joseph F. Quinn, Cyrus P. Zabetian, Ignacio F. Mata, C. Dirk Keene, Margaret Flanagan, Paul K. Crane, Thomas J. Grabowski, Kathleen S. Montine, Thomas J. Montine

Research output: Contribution to journalReview article

26 Scopus citations

Abstract

Three key elements to precision medicine are stratification by risk, detection of pathophysiological processes as early as possible (even before clinical presentation), and alignment of mechanism of action of intervention(s) with an individual's molecular driver(s) of disease. Used for decades in the management of some rare diseases and now gaining broad currency in cancer care, a precision medicine approach is beginning to be adapted to cognitive impairment and dementia. This review focuses on the application of precision medicine to address the clinical and biological complexity of two common neurodegenerative causes of dementia: Alzheimer disease and Parkinson disease.

Original languageEnglish (US)
Pages (from-to)500-506
Number of pages7
JournalAmerican Journal of Pathology
Volume186
Issue number3
DOIs
StatePublished - Mar 1 2016

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Precision medicine: Clarity for the complexity of dementia'. Together they form a unique fingerprint.

  • Cite this

    Cholerton, B., Larson, E. B., Quinn, J. F., Zabetian, C. P., Mata, I. F., Keene, C. D., Flanagan, M., Crane, P. K., Grabowski, T. J., Montine, K. S., & Montine, T. J. (2016). Precision medicine: Clarity for the complexity of dementia. American Journal of Pathology, 186(3), 500-506. https://doi.org/10.1016/j.ajpath.2015.12.001